Rezaeeyan Hadi, Shirzad Reza, McKee Trevor D, Saki Najmaldin
Research Center of Thalassemia & Hemoglobinopathy, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
WHO-Collaborating Centre for Reference and Research on Rabies, Pasteur Institute of Iran, Tehran, Iran.
APMIS. 2018 May;126(5):359-370. doi: 10.1111/apm.12818. Epub 2018 Apr 20.
Chemokines are cytokines that are involved in the movement of leukocytes and the occurrence of immune responses. It has recently been noted that these cytokines play a role in the movement of cancer cells to different parts of the body and create a suitable environment [i.e. (pre) metastatic niche] for their growth and proliferation. We studied the role of chemokines in the metastasis of cancer cells, as well as their involvement in the proliferation and growth of these cells. Relevant literature was identified by a PubMed search (2005-2017) of English language papers using the terms 'chemokine,' 'metastasis niche,' and 'organotropism.' Based on the nature of cancer cells, the expression of chemokine receptors on these cells leads to metastasis to various organs, which ultimately causes changes in different signaling pathways. Finally, the targeting of chemokines on cancer cells could prevent the metastasis of cancer cells toward different organs.
趋化因子是一类参与白细胞移动和免疫反应发生的细胞因子。最近有研究指出,这些细胞因子在癌细胞向身体不同部位的移动过程中发挥作用,并为其生长和增殖创造适宜的环境[即(前)转移微环境]。我们研究了趋化因子在癌细胞转移中的作用,以及它们在这些细胞增殖和生长过程中的参与情况。通过在PubMed数据库中检索(2005 - 2017年)英文文献,使用关键词“趋化因子”“转移微环境”和“器官趋向性”来确定相关文献。基于癌细胞的特性,这些细胞上趋化因子受体的表达会导致癌细胞转移至各个器官,最终引起不同信号通路的变化。最后,针对癌细胞的趋化因子靶向治疗可能会阻止癌细胞向不同器官转移。